Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 27;6(2):00017-2020.
doi: 10.1183/23120541.00017-2020. eCollection 2020 Apr.

Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics

Marco Caminati  1   2 , Andrea Vianello  3 , Margherita Andretta  4 , Anna Michela Menti  4 , Silvia Tognella  5 , Luca Degli Esposti  6 , Claudio Micheletto  7 , Chiara Bovo  8 , Gianenrico Senna  1
Affiliations

Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics

Marco Caminati et al. ERJ Open Res. .

Abstract

Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation. http://bit.ly/3cRTJB0.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M. Caminati has nothing to disclose. Conflict of interest: A. Vianello has nothing to disclose. Conflict of interest: M. Andretta has nothing to disclose. Conflict of interest: A.M. Menti has nothing to disclose. Conflict of interest: S. Tognella has nothing to disclose. Conflict of interest: L. Degli Esposti has nothing to disclose. Conflict of interest: C. Micheletto has nothing to disclose. Conflict of interest: C. Bovo has nothing to disclose. Conflict of interest: G. Senna has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Adherence rate in the study population.
See this image and copyright information in PMC

References

    1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2019 Available from: www.ginasthma.org. Date last accessed: November 2019.
    1. Corren J, Panettieri RA. How important is adherence to inhaled medications before starting a biologic therapy for asthma? J Allergy Clin Immunol Pract 2018; 6: 1578–1579. doi:10.1016/j.jaip.2018.07.007 - DOI - PubMed
    1. Blake KV. Improving adherence to asthma medications: current knowledge and future perspectives. Curr Opin Pulm Med 2017; 23: 62–70. doi:10.1097/MCP.0000000000000334 - DOI - PubMed
    1. Caminati M, Polk B, Rosenwasser LJ. What have recent advances in therapy taught us about severe asthma disease mechanisms? Expert Rev Clin Immunol 2019; 15: 1145–1153. doi:10.1080/1744666X.2020.1672536 - DOI - PubMed
    1. Komlósi ZI, Kovács N, Sokolowska M, et al. . Mechanisms of subcutaneous and sublingual aeroallergen immunotherapy: what is new? Immunol Allergy Clin North Am 2020; 40: 1–14. doi:10.1016/j.iac.2019.09.009 - DOI - PubMed

LinkOut - more resources